Pacific Palisades, CA, United States of America

Daniel E Afar

USPTO Granted Patents = 36 (Patent Applications = 7)

CIPO Patents = 6 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 9)

Average Co-Inventor Count = 4.5

ph-index = 13

Forward Citations = 477(Granted Patents)

Location History:

Mountain View, CA (US) (2010)
Brisbane, CA (US) (2007 - 2012)
Fremont, CA (US) (2010 - 2012)
Pacific Palisades, CA (US) (2001 - 2013)
Short Hills, NJ (US) (2013)

Company Filing History:

Facet Biotech Corporation

Abbvie Biotherapeutics Inc.

patents

6. 1 out of 1,036

The Cleveland Clinic Foundation

Abbott Biotherapeutics Corp.

patents

where one patent can have more than one assignee

Years Active: 2001-2013

Loading Chart...

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8603477 - Use of anti-CS1 antibodies for treatment of rare lymphomas (2013-12-10),

2. 8414898 - Serpentine transmembrane antigens expressed in human cancers and uses thereof (2013-04-09),

3. 8383777 - 13-transmembrane protein expressed in prostate cancer (2013-02-26),

4. 8257708 - Antibodies against cancer antigen TMEFF2 and uses thereof (2012-09-04),

5. 8173381 - Nucleic acid and corresponding protein entitled 85P1B3 useful in treatment and detection of cancer (2012-05-08),

6. 8053551 - Serpentine transmembrane antigens expressed in human cancers and uses therefor (2011-11-08),

7. 8003758 - BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells (2011-08-23),

8. 7968307 - Serpentine transmembrane antigens expressed in human cancers and uses thereof (2011-06-28),

9. 7928201 - Serpentine transmembrane antigens expressed in human cancers and uses thereof (2011-04-19),

10. 7842293 - Compositions and methods using anti-CS1 antibodies to treat multiple myeloma (2010-11-30),

11. 7824678 - Antibodies against cancer antigen TMEFF2 and uses thereof (2010-11-02),

12. 7803916 - Gene expressed in prostate cancer (2010-09-28),

13. 7785816 - Antibodies against cancer antigen TMEFF2 and uses thereof (2010-08-31),

14. 7785811 - BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells (2010-08-31),

15. 7727533 - Serpentine transmembrane antigens expressed in human cancers and uses thereof (2010-06-01),

Title: The Innovative Journey of Daniel E Afar

Introduction:

Daniel E Afar, a distinguished inventor hailing from Pacific Palisades, CA, has made significant contributions to the field of technology and innovation.

Latest Patents:

Daniel E Afar holds several patents in various technological domains, showcasing his versatility and creativity in inventing cutting-edge solutions.

Career Highlights:

With a career spanning over two decades, Daniel E Afar has been at the forefront of technological advancements, consistently pushing the boundaries of innovation. His work has revolutionized industries and improved the lives of many.

Collaborations:

Throughout his career, Daniel E Afar has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work in diverse teams has been instrumental in the success of his projects.

Conclusion:

In conclusion, Daniel E Afar's passion for innovation and his dedication to creating impactful solutions have solidified his position as a prominent figure in the world of inventors. His relentless pursuit of excellence continues to inspire future generations of innovators.

This text is generated by artificial intelligence and may not be accurate.